Short Interest in BlackRock Capital Allocation Term Trust (NYSE:BCAT) Increases By 13.4%

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 128,600 shares, an increase of 13.4% from the November 30th total of 113,400 shares. Based on an average daily volume of 402,500 shares, the short-interest ratio is presently 0.3 days.

BlackRock Capital Allocation Term Trust Trading Up 0.3 %

BCAT traded up $0.05 on Wednesday, reaching $15.15. The company had a trading volume of 676,663 shares, compared to its average volume of 370,566. BlackRock Capital Allocation Term Trust has a 52-week low of $14.76 and a 52-week high of $17.18. The business has a 50 day simple moving average of $15.98 and a 200 day simple moving average of $16.22.

BlackRock Capital Allocation Term Trust Increases Dividend

The company also recently declared a monthly dividend, which was paid on Monday, December 23rd. Shareholders of record on Monday, December 16th were paid a dividend of $0.2892 per share. The ex-dividend date of this dividend was Monday, December 16th. This represents a $3.47 annualized dividend and a yield of 22.91%. This is a positive change from BlackRock Capital Allocation Term Trust's previous monthly dividend of $0.10.

Insider Activity at BlackRock Capital Allocation Term Trust

In other news, major shareholder Saba Capital Management, L.P. sold 66,481 shares of the firm's stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $16.48, for a total value of $1,095,606.88. Following the completion of the transaction, the insider now directly owns 15,603,000 shares in the company, valued at approximately $257,137,440. This trade represents a 0.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders have sold 530,336 shares of company stock worth $8,738,508.

Institutional Trading of BlackRock Capital Allocation Term Trust

Several hedge funds and other institutional investors have recently bought and sold shares of BCAT. Cambridge Investment Research Advisors Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust by 4.3% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 133,238 shares of the company's stock valued at $2,186,000 after acquiring an additional 5,438 shares during the last quarter. Blue Bell Private Wealth Management LLC boosted its position in BlackRock Capital Allocation Term Trust by 4.0% during the 2nd quarter. Blue Bell Private Wealth Management LLC now owns 104,722 shares of the company's stock valued at $1,718,000 after buying an additional 4,059 shares during the period. Prevail Innovative Wealth Advisors LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust in the second quarter valued at about $1,452,000. Almitas Capital LLC bought a new position in BlackRock Capital Allocation Term Trust during the 2nd quarter valued at approximately $728,000. Finally, Quarry LP raised its holdings in shares of BlackRock Capital Allocation Term Trust by 68.4% during the second quarter. Quarry LP now owns 69,034 shares of the company's stock valued at $1,133,000 after acquiring an additional 28,045 shares in the last quarter. Hedge funds and other institutional investors own 36.12% of the company's stock.

About BlackRock Capital Allocation Term Trust

-